These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1549456)
1. [Interferon treatment in chronic myeloid leukemia]. Simonsson B Nord Med; 1992; 107(3):76-7, 79. PubMed ID: 1549456 [TBL] [Abstract][Full Text] [Related]
2. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group. Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674 [TBL] [Abstract][Full Text] [Related]
3. Approaches to the treatment of chronic myeloid leukemia. Savage DG; Goldman JM Int J Hematol; 1994 Jul; 60(1):1-21. PubMed ID: 7919235 [TBL] [Abstract][Full Text] [Related]
4. [Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation]. Urabe A Gan To Kagaku Ryoho; 1999 Sep; 26(10):1381-6. PubMed ID: 10500523 [TBL] [Abstract][Full Text] [Related]
5. Interferon alpha in the treatment of chronic myelogenous leukemia. Robak T Arch Immunol Ther Exp (Warsz); 1998; 46(6):347-53. PubMed ID: 9883313 [TBL] [Abstract][Full Text] [Related]
6. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia. Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406 [TBL] [Abstract][Full Text] [Related]
7. [Recent progress in therapy for chronic myelogenous leukemia]. Urabe A Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158 [TBL] [Abstract][Full Text] [Related]
8. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia. Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677 [TBL] [Abstract][Full Text] [Related]
9. [Interferon-alpha in the treatment of chronic myeloid leukemia]. Guilhot F Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394 [No Abstract] [Full Text] [Related]
10. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases]. Nese M; de Bellis R; Urtiarte R; Di Landro J Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047 [TBL] [Abstract][Full Text] [Related]
11. [Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia]. Koyama S; Aoki S; Furukawa T; Takahashi M; Kishi K; Koike T; Moriyama Y; Hattori A; Shibata A Rinsho Ketsueki; 1991 Dec; 32(12):1577-9. PubMed ID: 1779460 [TBL] [Abstract][Full Text] [Related]
12. [Interferon-alpha therapy in chronic myeloid leukemia]. Lutz D Wien Med Wochenschr; 1993; 143(16-17):416-9. PubMed ID: 8273364 [TBL] [Abstract][Full Text] [Related]
13. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167 [TBL] [Abstract][Full Text] [Related]
15. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886 [TBL] [Abstract][Full Text] [Related]
16. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results. Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418 [TBL] [Abstract][Full Text] [Related]